Interpreting Color by Bisulfite Mode

IGV v2.1 (released April 2012) and onwards offer a coloring by bisulfite mode option from the right-click pop-up menu for alignments. The six offered modes are summarized in the table, and are explained further on this page.

For a general overivew of viewing alignments in IGV, see Viewing Alignments.

Coloring by bisulfite mode supports visualization of DNA libraries that have undergone bisulfite conversion and sequencing. The mode supports visualization of alignments from the following and similar techniques:

  • BS-Seq, bisulfite sequencing
  • RRBS-Seq, reduced representation bisulfite sequencing
  • TAB-Seq, Tet-assisted bisulfite sequncing
  • NOMe-Seq
IGV Bisulfite mode description relevance
  • CpG
  • Canonical methylation target site in eukaryotes
  • H represents any nucleotide but guanine (H comes after G)

Additional methylation sites:

  • For mammals in a cell-type dependent manner. Pervasive in human embryonic stem cells (Lister 2009). For example, in H1 stem cells comprises almost 25% of all cytosines at which DNA methylation is identified compared to 99.98% mCG in IMR90 cells.
  • In plants serve as additional canonical methylation target sites.
  • inclusive of WCG
  • W represents A or T (Weak)
  • ACG, TCG

When bisulfite sequence tracks are initially loaded, default coloring of mismatches against the reference will show red T's and green A's. When coloring is switched to bisulfite mode, two new coloring schema are applied and together allow you to visually distinguish read strand and bisulfite conversion status.

  1. Reads are colored by DNA strand. For paired reads, this is the same as coloring by first-of-pair strand.
    • Gray for forward reads or forward read first pairs (F1 or F1R2)
    • Sage for reverse reads or reverse read first pairs (R1 or R1F2)
  2. The chosen mode is highlighted in reads with a red or blue nucleotide corresponding to the position of the cytosine in the reference genome.
    • For forward reads, a red C denotes a nonconverted cytosine, implying methyl or other protection, while a blue T denotes a bisulfite converted cytosine.
    • For reverse reads, a red G denotes a nonconverted cytosine, implying methyl or other protection, while a blue A denotes a bisulfite converted cytosine.
    • In zoomed-out views, colored nucleotides are represented by colored lines.

Because not all mode matching sites are biologically relevant in the context of methylation, bisulfite experiments compare changes in methylation between a control sample and the variable. When comparing two samples, a change in methylation status will be marked by a difference in color for a given site. Red to blue indicates loss of methylation, or hypomethylation; blue to red indicates increased protection by methylation, or hypermethylation, as shown for the tumor sample in the screenshot below which visualizes data from Berman et al (2012).

Bisulfite sequencing (BS-Seq) identifies sites of DNA methylation

Coloring by bisulfite mode in IGV allows for visualization of alignments of BS-Seq reads, a DNA-modification technique used to distinguish sites of DNA methylation and hydroxymethylation in epigenetic studies. Alignments in IGV are against a reference genome of correct sequence as coloring is based on deviations from the reference sequence. Read alignment may have been against a bisulfite-transformed genome sequence, in which case genomic coordinates would still be for that of the original reference genome.

In DNA methylation, the methyl CH3 group is added to the cytosine base at the carbon 5 position (5-meC) in a sequence-context dependent manner. In mammals this context is typically CpG dinucleotides, and in plants this is CpG, CpHpG, and CpHpH di- and tri-nucleotides. These correspond to the CG, CHG, and CHH bisulfite coloring modes in IGV. The IUPAC ambiguity code H represents any nucleotide but guanine.

Promoter methylation is typically associated with repression, while genic methylation correlates with transcriptional activity.

BS-Seq exploits the different sensitivities of cytosine and 5-meC to bisulfite

Bisulfite modification exploits the different sensitivities of cytosine and 5-meC to deamination by bisulfite under acidic conditions. Cytosine undergoes conversion to uracil whereas 5-meC is unmodified and remains intact. The uracil is subsequently converted to thymine after PCR amplification while 5-meC residues remain cytosines.

A number of the different genome-wide methylome technologies use bisulfite chemistry and this IGV mode applies to those that in addition sequence the bisulfite converted DNA, such as by Illumina high-throughput sequencing. These include whole-genome bisulfite sequencing (WGBS) and reduced-representation-bisulfite sequencing (RRBS), both of which provide single-nucleotide resolution.

RRBS targets bisulfite sequencing to an enriched population of the genome while WGBS porportedly determines the methylation state of every cytosine in the target sequence. However, as with any technique limitations exist, including the inability to discriminate 5-meC from 5-hydroxymethylcytosine (5-hmeC) modifications, which was discovered to be pervasive in mammalian DNA in 2009 (Yu, Cell 2012).

Multiple techniques are used to distinguish 5-hmeC from 5-meC. Of relevance to coloring by bisulfite mode in IGV is TAB-Seq (Tet-assisted bisulfite sequencing), in which 5-hmeC sites are protected by glucosylation prior to bisulfite conversion. Because 5-meC sites remain unprotected from mTet1 oxidation to 5-carboxylcytosine (5-caC), and subsequent bisulfite conversion, only 5-hmeC site cytosines remain unchanged in reads (Yu, Nature Protocols 2012).

The following figure diagrams the nucleotide conversions that occur for a methylated versus unmethylated locus during bisulfite conversion and PCR, and IGV's corresponding coloring of these sites in CG bisulfite mode.

For a given DNA fragment, four strands arise after treatment and PCR amplification. These are the original top strand (OT), the original bottom strand (OB), and strands which are complementary to OT and OB  (CTOT and CTOB). IGV visualizes reads in one direction, and for the given direction reads from the opposite strand are automatically displayed as the reverse complement. Therefore, OT and CTOT reads are displayed in the reference-forward direction (gray) while OB and CTOB reads are displayed in the reverse direction (sage) and are differentially colored as indicated.

To sort reads by strand, use the right-click pop-up menu on the alignment track.

You can also infer the read-strand by the specific nucleotides that are highlighted by the mode.  OT and CTOT yield methylation information for cytosines on the top strand (C and T highlighted), while OB and CTOB will give methylation information for the paired complement, that is for guanines paired to the methylatable cytosines (G and A highlighted).

NOMe-Seq additionally determines nucleosome positioning

In addition to detecting methylation states, bisulfite conversion is used in footprinting studies. For example to determine nucleosome positioning in yeast and mammalian cells.

The additional IGV color modes--HCG, GCH, and WCG (diagram)--are relevant to NOMe-Seq, a genome-wide nucleosome footprinting and methylome sequencing method (Kelly 2012). This method obtains nucleosome positioning information based on the GpC methyltransferase M.CviPI accessibility to GpC sites, and at the same time obtains endogenous DNA methylation information from CpG sites.

  • GCH cytosines are used to plot enzyme accessibility, that is, nucleosome protection or occupancy.
  • HCG cytosines are used for endogenous methylation. GCG is excluded due to ambiguity between endogenous and enzymatic methylation.
    • The authors note that in their context, GCGs represent less than 0.24% of the genome and make up only 5.6% of all GC dinucleotides.
    • In addition, 93.4% of GCG trinucleotides have a GCH within 20 bp (and half of these within 5 bp) from which nucleosome occupancy information can be derived.
  • Authors use WCG instead of HCG in certain calculations to exclude off-target activity of M.CviPI on CCG sites.


Berman, Benjamin P, Daniel J Weisenberger, Joseph F Aman, Toshinori Hinoue, Zachary Ramjan, Yaping Liu, Houtan Noushmehr, et al. 2012. “Regions of Focal DNA Hypermethylation and Long-Range Hypomethylation in Colorectal Cancer Coincide with Nuclear Lamina-Associated Domains.” Nature Genetics 44 (1): 40–46. doi:10.1038/ng.969.

Kelly, Theresa K, Yaping Liu, Fides D Lay, Gangning Liang, Benjamin P Berman, and Peter a Jones. 2012. “Genome-Wide Mapping of Nucleosome Positioning and DNA Methylation within Individual DNA Molecules Genome-Wide Mapping of Nucleosome Positioning and DNA Methylation within Individual DNA Molecules,” 2497–2506. doi:10.1101/gr.143008.112.

Lister, Ryan, Mattia Pelizzola, Robert H Dowen, R David Hawkins, Gary Hon, Julian Tonti-Filippini, Joseph R Nery, et al. 2009. “Human DNA Methylomes at Base Resolution Show Widespread Epigenomic Differences.” Nature 462 (7271). Nature Publishing Group: 315–22. doi:10.1038/nature08514.

Stirzaker, Clare, Phillippa C. Taberlay, Aaron L. Statham, and Susan J. Clark. 2014. “Mining Cancer Methylomes: Prospects and Challenges.” Trends in Genetics 30 (2). Elsevier Ltd: 75–84. doi:10.1016/j.tig.2013.11.004.

Yu, Miao, Gary C Hon, Keith E Szulwach, Chun-Xiao Song, Peng Jin, Bing Ren, and Chuan He. 2012. “Tet-Assisted Bisulfite Sequencing of 5-Hydroxymethylcytosine.” Nature Protocols 7 (12): 2159–70. doi:10.1038/nprot.2012.137.

Yu, Miao, Gary C Hon, Keith E Szulwach, Chun-Xiao Song, Liang Zhang, Audrey Kim, Xuekun Li, et al. 2012. “Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome.” Cell 149 (6): 1368–80. doi:10.1016/j.cell.2012.04.027.